PEFICITINIB: A POTENTIAL TREATMENT FOR RA ARTHRITIS ?

Peficitinib, a experimental medication targeting the spleen tyrosine kinase pathway , offers a encouraging breakthrough in the treatment of RA . Early clinical trials suggest that it can demonstrably reduce swelling and bolster physical capabilities in individuals who have the ailment, particular